Quick Search


 

Result Summaries: zidovudine

ViiV
Study ID
   Phase    Title Summary (Download)
104774 phase 4 Microalbuminuria as a Predictor of the Development of Kidney Disease in HIV-Positive Patients (0 citation(s)) Click here to download result summary.
111945_2 N/A Studies using DAD - HIV and Hepatitis Coinfection Initiative (5 citation(s)) Click here to download result summary.
111950_2 n\a Fractures over time stratified by HIV infection and Antiretroviral Therapy (ART) exposure (0 citation(s)) Click here to download result summary.
112872_2 n\a HIV treatment and CVD events - Ingenix. Retrospective Database Analysis of Patients with Human Immunodeficiency Virus (HIV) Treatment and Cardiovascular Disease (CVD) Events (0 citation(s)) Click here to download result summary.
112874_2 N/A Incidence and Risk Factors for New-onset Diabetes in HIV-infected Patients. The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study (1 citation(s)) Click here to download result summary.
112877_4 N/A Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration (5 citation(s)) Click here to download result summary.
112878_1 N/A Diabetes Mellitus, Preexisting Coronary Heart Disease, and the Risk of Subsequent Coronary Heart Disease Events in Patients Infected With Human Immunodeficiency Virus (2 citation(s)) Click here to download result summary.
112884_2 N/A The metabolic syndrome in the DAD Study (2 citation(s)) Click here to download result summary.
112885_2 N/A Antiretroviral Pregnancy Registry (APR)-Risk of birth defects associated with exposure to GSK HIV drugs during pregnancy (1 citation(s)) Click here to download result summary.
112886_1 N/A Changes over time in risk factors for cardiovascular disease and use of Lipid-Lowering drugs in HIV-infected individuals and impact on myocardial infarction. (0 citation(s)) Click here to download result summary.
112887_2 N/A Studies using DAD - Effects of different interventions to improve ART-associated dyslipidemia (1 citation(s)) Click here to download result summary.
113039_2 N/A Studies using DAD - Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: Are different antiretroviral drugs associated with different lipid profiles? (1 citation(s)) Click here to download result summary.
113154_2 N/A Predictors of hypertension and changes of blood pressure in HIV-infected patients (2 citation(s)) Click here to download result summary.
113156_2 N/A Studies using the VA - Studies done under the Oversight Committee for the Evaluation of the metabolic complications of HAART (2 citation(s)) Click here to download result summary.
113329_2 n\a Lactic acid levels in children pre- and perinatally treated with antiretrovirals to prevent HIV transmission (Giaquinto; Hyperlactatemia in infants with in utero exposure to ZDV/3TC ) (2 citation(s)) Click here to download result summary.
COD10001 Phase 1 A pilot open-labeled, randomized, parallel cohort, pharmacokinetic and pharmacodynamic, multicenter trial of zidovudine (RETROVIR) 600 mg once daily compared to zidovudine 300 mg BID monotherapy for 14 days in HIV infected, therapy naïve patients. (0 citation(s)) Click here to download result summary.
COD20002 Phase 2 A Phase II, Open-Label, Multicenter, Randomized, Parallel Group, 14 Day Pilot Study of Monotherapy with Zidovudine 600mg Once Daily Compared to Zidovudine 300mg Twice Daily in HIV-Infected, Antiretroviral-Naïve Subjects. (1 citation(s)) Click here to download result summary.
EPI40007 Phase 4 The Antiretroviral Pregnancy Registry (APR, Registry) (2 citation(s)) Click here to download result summary.